Article Details

Curve Therapeutics in US$1.7bn deal with MSD - European Biotechnology

Retrieved on: 2022-02-16 09:21:26

Tags for this article:

Click the tags to see associated articles and topics

Curve Therapeutics in US$1.7bn deal with MSD - European Biotechnology. View article details on hiswai:

Excerpt

Curve Therapeutics has inked a contract with US pharma giant Merck & Co. (MSD) to screen novel small molecule drug candidates against five MSD ...

Article found on: european-biotechnology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up